Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2007 1
2008 3
2009 2
2010 3
2011 3
2012 1
2013 4
2014 1
2015 3
2016 2
2017 2
2018 1
2020 2
2021 4
2022 5
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Pathways to Parkinson's disease: a spotlight on 14-3-3 proteins.
Giusto E, Yacoubian TA, Greggio E, Civiero L. Giusto E, et al. Among authors: yacoubian ta. NPJ Parkinsons Dis. 2021 Sep 21;7(1):85. doi: 10.1038/s41531-021-00230-6. NPJ Parkinsons Dis. 2021. PMID: 34548498 Free PMC article. Review.
Targets for neuroprotection in Parkinson's disease.
Yacoubian TA, Standaert DG. Yacoubian TA, et al. Biochim Biophys Acta. 2009 Jul;1792(7):676-87. doi: 10.1016/j.bbadis.2008.09.009. Epub 2008 Oct 1. Biochim Biophys Acta. 2009. PMID: 18930814 Free PMC article. Review.
Target validation: the Parkinson disease perspective.
Standaert DG, Yacoubian TA. Standaert DG, et al. Among authors: yacoubian ta. Dis Model Mech. 2010 May-Jun;3(5-6):259-62. doi: 10.1242/dmm.004192. Dis Model Mech. 2010. PMID: 20427553 Free article. No abstract available.
007 (x2)-3-3: 14-3-3 Targeted Compounds as Double Agents.
Gannon M, Yacoubian TA. Gannon M, et al. Among authors: yacoubian ta. Trends Pharmacol Sci. 2020 Jul;41(7):431-433. doi: 10.1016/ Epub 2020 May 10. Trends Pharmacol Sci. 2020. PMID: 32402470 Free PMC article.
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain.
Xu E, Boddu R, Abdelmotilib HA, Sokratian A, Kelly K, Liu Z, Bryant N, Chandra S, Carlisle SM, Lefkowitz EJ, Harms AS, Benveniste EN, Yacoubian TA, Volpicelli-Daley LA, Standaert DG, West AB. Xu E, et al. Among authors: yacoubian ta. Mol Neurodegener. 2022 Jan 10;17(1):7. doi: 10.1186/s13024-021-00509-5. Mol Neurodegener. 2022. PMID: 35012605 Free PMC article.
α-Synuclein overexpression represses 14-3-3θ transcription.
Ding H, Fineberg NS, Gray M, Yacoubian TA. Ding H, et al. Among authors: yacoubian ta. J Mol Neurosci. 2013 Nov;51(3):1000-9. doi: 10.1007/s12031-013-0086-5. Epub 2013 Aug 4. J Mol Neurosci. 2013. PMID: 23912650 Free PMC article.
Brain and Systemic Inflammation in De Novo Parkinson's Disease.
Yacoubian TA, Fang YD, Gerstenecker A, Amara A, Stover N, Ruffrage L, Collette C, Kennedy R, Zhang Y, Hong H, Qin H, McConathy J, Benveniste EN, Standaert DG. Yacoubian TA, et al. Mov Disord. 2023 May;38(5):743-754. doi: 10.1002/mds.29363. Epub 2023 Feb 28. Mov Disord. 2023. PMID: 36853618
36 results